Tianjin Tianyao Pharmaceuticals Co Ltd Capital Reinvestment Ratio
Tianjin Tianyao Pharmaceuticals Co Ltd capital reinvestment ratio. Tianjin Tianyao Pharmaceuticals Co Ltd (600488) has a Capital Reinvestment Ratio of 1.33x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥13.19 Million) in capital expenditures (CN¥17.49 Million). Check 600488 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Tianjin Tianyao Pharmaceuticals Co Ltd (2000–2024)
Capital reinvestment ratio of Tianjin Tianyao Pharmaceuticals Co Ltd from 2000 to 2024. This chart tracks Tianjin Tianyao Pharmaceuticals Co Ltd's Capital Reinvestment Ratio across 23 annual periods. Also explore Tianjin Tianyao Pharmaceuticals Co Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Tianjin Tianyao Pharmaceuticals Co Ltd Capital Reinvestment Ratio by Year (2000–2024)
Tianjin Tianyao Pharmaceuticals Co Ltd capital reinvestment ratio by year from 2000 to 2024. For the full cash flow conversion analysis, see cash efficiency ratio of Tianjin Tianyao Pharmaceuticals Co Ltd.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.14x | CN¥569.37 Million | CN¥77.74 Million | ▼ -19.7% |
| 2023 | 0.17x | CN¥783.01 Million | CN¥133.15 Million | ▼ -45.0% |
| 2022 | 0.31x | CN¥653.52 Million | CN¥202.20 Million | ▼ -73.6% |
| 2021 | 1.17x | CN¥316.89 Million | CN¥370.84 Million | ▼ -11.5% |
| 2020 | 1.32x | CN¥346.88 Million | CN¥458.51 Million | ▲ +32.3% |
| 2019 | 1.00x | CN¥279.37 Million | CN¥279.04 Million | ▼ -7.1% |
| 2018 | 1.08x | CN¥189.27 Million | CN¥203.58 Million | ▲ +5.1% |
| 2016 | 1.02x | CN¥63.32 Million | CN¥64.78 Million | ▲ +192.3% |
| 2015 | 0.35x | CN¥129.50 Million | CN¥45.32 Million | ▲ +272.9% |
| 2014 | 0.09x | CN¥178.76 Million | CN¥16.78 Million | ▼ -97.4% |
| 2013 | 3.67x | CN¥84.55 Million | CN¥310.08 Million | ▼ -35.8% |
| 2012 | 5.71x | CN¥13.23 Million | CN¥75.59 Million | ▲ +614.5% |
| 2011 | 0.80x | CN¥78.47 Million | CN¥62.76 Million | ▼ -36.8% |
| 2010 | 1.26x | CN¥116.82 Million | CN¥147.76 Million | ▲ +172.0% |
| 2009 | 0.46x | CN¥435.13 Million | CN¥202.32 Million | ▼ -71.5% |
| 2008 | 1.63x | CN¥219.31 Million | CN¥357.63 Million | ▲ +17.8% |
| 2007 | 1.38x | CN¥162.33 Million | CN¥224.74 Million | ▼ -1.0% |
| 2006 | 1.40x | CN¥50.72 Million | CN¥70.91 Million | ▲ +15.5% |
| 2004 | 1.21x | CN¥110.30 Million | CN¥133.47 Million | ▼ -68.2% |
| 2003 | 3.81x | CN¥45.77 Million | CN¥174.24 Million | ▲ +0.7% |
| 2002 | 3.78x | CN¥45.28 Million | CN¥171.20 Million | ▲ +459.5% |
| 2001 | 0.68x | CN¥71.87 Million | CN¥48.57 Million | ▼ -23.5% |
| 2000 | 0.88x | CN¥41.06 Million | CN¥36.29 Million | — |